Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.

被引：0
作者：
Agrawal, Vaibhav [1 ]
Castillo, Jose Isaac [1 ]
Raup, Kelly [1 ]
Girton, Treanna [1 ]
Collins, Scott R. [1 ]
Brady, James O. [1 ]
Khan, Sharif S. [1 ]
Vadakara, Joseph [1 ]
机构：
[1] Geisinger Med Ctr, Danville, PA 17822 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e19035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19035
引用
收藏
页数：2
相关论文
共 50 条
[41]   Efficacy of 90Y-Ibritumomab Tiuxetan in marginal-zone lymphoma (MZL) [J].
Vanazzi, Anna ;
Ferrucci, Pier Francesco ;
Grana, Chiara ;
Pruneri, Giancarlo ;
Crosta, Cristiano ;
Pinto, Antonello ;
Chinol, Marco ;
Paganelli, Giovanni ;
Martinelli, Giovanni .
BLOOD, 2007, 110 (11) :196B-197B
[42]   Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET [J].
Saiyada N. F. Rizvi ;
Otto J. Visser ;
Maria J. W. D. Vosjan ;
Arthur van Lingen ;
Otto S. Hoekstra ;
Josée M. Zijlstra ;
Peter C. Huijgens ;
Guus A. M. S. van Dongen ;
Mark Lubberink .
European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 :512-520
[43]   90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging [J].
Iagaru, Andrei ;
Gambhir, Sanjiv Sam ;
Goris, Michael L. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (11) :1809-1812
[44]   Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET [J].
Rizvi, Saiyada N. F. ;
Visser, Otto J. ;
Vosjan, Maria J. W. D. ;
van Lingen, Arthur ;
Hoekstra, Otto S. ;
Zijlstra, Josee M. ;
Huijgens, Peter C. ;
van Dongen, Guus A. M. S. ;
Lubberink, Mark .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (03) :512-520
[45]   Update on the rational use of 90Y-ibritumomab tiuxetan in the treatment of follicular lymphoma [J].
Lehnert, Martina ;
Ludwig, Heinz ;
Zojer, Niklas .
ONCOTARGETS AND THERAPY, 2009, 2 :199-208
[46]   Efficacy and safety of yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma [J].
Doyle, Catherine ;
Smith, Johnna ;
Bello, Celeste M. ;
Sokol, Lubomir ;
El-Haddad, Ghassan .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
[47]   Radioimmunotherapy with 90Y-ibritumomab tiuxetan for a hemodialysis patient with relapsed follicular lymphoma [J].
Fukuno, Kenji ;
Tsurumi, Hisashi ;
Yamada, Toshiki ;
Iida, Takayoshi ;
Takahashi, Takeshi ;
Moriwaki, Hisataka .
LEUKEMIA & LYMPHOMA, 2013, 54 (12) :2731-2733
[48]   90Yttrium-ibritumomab tiuxetan:: a novel treatment for non-Hodgkin's lymphoma [J].
Blum, KA ;
Bartlett, NL .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) :1323-1331
[49]   Safety and efficacy of retreating follicular non-Hodgkin's lymphoma with 90Y ibritumomab tiuxetan (zevalin). [J].
Shah, J. ;
Mueh, I. ;
Lister, J. ;
Jasthy, S. ;
Gregory, M. ;
Mckay, C. ;
Krumdieck, R. ;
Forero, A. .
JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) :S303-S303
[50]   The role of radioimmunotherapy with yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma [J].
Cheson, BD .
BIODRUGS, 2005, 19 (05) :309-322
12345